NO20045497L - Fremgangsmate for fremstilling av 5-(1,3-oksazol-2-yl)benzosyrederivater - Google Patents
Fremgangsmate for fremstilling av 5-(1,3-oksazol-2-yl)benzosyrederivaterInfo
- Publication number
- NO20045497L NO20045497L NO20045497A NO20045497A NO20045497L NO 20045497 L NO20045497 L NO 20045497L NO 20045497 A NO20045497 A NO 20045497A NO 20045497 A NO20045497 A NO 20045497A NO 20045497 L NO20045497 L NO 20045497L
- Authority
- NO
- Norway
- Prior art keywords
- sub
- oxazol
- preparation
- benzoic acid
- acid derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39028502P | 2002-06-20 | 2002-06-20 | |
| US45047803P | 2003-02-27 | 2003-02-27 | |
| PCT/US2003/019585 WO2004000821A1 (en) | 2002-06-20 | 2003-06-20 | Process for preparing 5-(1, 3-oxazol-2-yl) benzoic acid derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20045497D0 NO20045497D0 (no) | 2004-12-16 |
| NO20045497L true NO20045497L (no) | 2005-03-07 |
Family
ID=30003150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20045497A NO20045497L (no) | 2002-06-20 | 2004-12-16 | Fremgangsmate for fremstilling av 5-(1,3-oksazol-2-yl)benzosyrederivater |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US7115747B2 (enExample) |
| EP (1) | EP1532123B1 (enExample) |
| JP (1) | JP2005533811A (enExample) |
| CN (1) | CN1324017C (enExample) |
| AT (1) | ATE370131T1 (enExample) |
| AU (1) | AU2003249344A1 (enExample) |
| BR (1) | BR0312439A (enExample) |
| CA (1) | CA2489988A1 (enExample) |
| CO (1) | CO5670350A2 (enExample) |
| DE (1) | DE60315664D1 (enExample) |
| EA (1) | EA008389B1 (enExample) |
| IL (1) | IL165763A0 (enExample) |
| MX (1) | MXPA04012630A (enExample) |
| NO (1) | NO20045497L (enExample) |
| NZ (1) | NZ537390A (enExample) |
| PL (1) | PL374999A1 (enExample) |
| WO (1) | WO2004000821A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0316629A (pt) * | 2002-11-27 | 2005-10-11 | Elan Pharm Inc | Uréias e carbamatos substituìdos |
| TW200738701A (en) * | 2005-07-26 | 2007-10-16 | Du Pont | Fungicidal carboxamides |
| US7872009B2 (en) * | 2005-11-21 | 2011-01-18 | Amgen Inc. | Beta-Secretase modulators and methods of use |
| US7838676B2 (en) * | 2005-11-21 | 2010-11-23 | Amgen Inc. | Beta-secretase modulators and methods of use |
| US7745484B2 (en) | 2005-11-21 | 2010-06-29 | Amgen Inc. | Beta-secretase modulators and methods of use |
| EP1971598A1 (en) | 2005-11-21 | 2008-09-24 | Amgen Inc. | Beta-secretase modulators and methods of use |
| WO2008137954A2 (en) * | 2007-05-07 | 2008-11-13 | Environmental Packaging Technologies Limited | Universal shipping container |
| US8163909B2 (en) | 2007-05-25 | 2012-04-24 | Amgen Inc. | Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
| JP5440984B2 (ja) * | 2007-05-25 | 2014-03-12 | アムジエン・インコーポレーテツド | β−セクレターゼ修飾剤としての置換ヒドロキシエチルアミン化合物および使用方法 |
| US7803809B2 (en) | 2008-11-12 | 2010-09-28 | Amgen Inc. | Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use |
| KR20110073511A (ko) | 2008-09-11 | 2011-06-29 | 암젠 인크 | 베타세크레타제 조절제로서의 스피로-테트라사이클릭 고리 화합물 및 사용 방법 |
| WO2011063233A1 (en) | 2009-11-23 | 2011-05-26 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| EP2504330A1 (en) | 2009-11-23 | 2012-10-03 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| CA2788363A1 (en) | 2010-01-19 | 2011-07-28 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| JP5584352B2 (ja) | 2010-03-15 | 2014-09-03 | アムジエン・インコーポレーテツド | β−セクレターゼ調節剤としてのアミノ−ジヒドロオキサジン系およびアミノ−ジヒドロチアジン系スピロ化合物ならびにそれらの医学的用途 |
| CA2791281A1 (en) | 2010-03-15 | 2011-09-22 | Amgen Inc. | Spiro-tetracyclic ring compounds as beta-secretase modulators |
| EP2673279A1 (en) | 2011-02-07 | 2013-12-18 | Amgen Inc. | 5-amino-oxazepine and 5-amino-thiazepane compounds as beta-secretase antagonists and methods of use |
| EP2758406A1 (en) | 2011-09-21 | 2014-07-30 | Amgen Inc. | Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
| US9725469B2 (en) | 2012-11-15 | 2017-08-08 | Amgen, Inc. | Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
| US11272751B2 (en) | 2016-03-01 | 2022-03-15 | Nicholas Popejoy | Protective headgear, impact diffusing systems and methods |
| US9462841B1 (en) | 2016-03-01 | 2016-10-11 | William Popejoy | Protective headgear and shoulder pad apparatus and methods |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20020276A1 (es) * | 2000-06-30 | 2002-04-06 | Elan Pharm Inc | COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER |
| CA2462851A1 (en) | 2001-10-04 | 2003-04-10 | Elan Pharmaceuticals, Inc. | Hydroxypropylamines |
| AR039555A1 (es) * | 2001-11-08 | 2005-02-23 | Upjohn Co | Derivados n,n'-sustituidos de 1,3-diamino-2-hidroxipropano |
| GB0325830D0 (en) * | 2003-11-05 | 2003-12-10 | Novartis Ag | Organic compounds |
-
2003
- 2003-06-20 CN CNB038144476A patent/CN1324017C/zh not_active Expired - Fee Related
- 2003-06-20 MX MXPA04012630A patent/MXPA04012630A/es active IP Right Grant
- 2003-06-20 NZ NZ537390A patent/NZ537390A/en unknown
- 2003-06-20 PL PL03374999A patent/PL374999A1/xx unknown
- 2003-06-20 CA CA002489988A patent/CA2489988A1/en not_active Abandoned
- 2003-06-20 JP JP2004516055A patent/JP2005533811A/ja active Pending
- 2003-06-20 DE DE60315664T patent/DE60315664D1/de not_active Expired - Lifetime
- 2003-06-20 AU AU2003249344A patent/AU2003249344A1/en not_active Abandoned
- 2003-06-20 EA EA200401510A patent/EA008389B1/ru unknown
- 2003-06-20 AT AT03761206T patent/ATE370131T1/de not_active IP Right Cessation
- 2003-06-20 US US10/600,100 patent/US7115747B2/en not_active Expired - Fee Related
- 2003-06-20 EP EP03761206A patent/EP1532123B1/en not_active Expired - Lifetime
- 2003-06-20 WO PCT/US2003/019585 patent/WO2004000821A1/en not_active Ceased
- 2003-06-20 BR BR0312439-8A patent/BR0312439A/pt not_active IP Right Cessation
-
2004
- 2004-12-14 IL IL16576304A patent/IL165763A0/xx unknown
- 2004-12-16 NO NO20045497A patent/NO20045497L/no not_active Application Discontinuation
-
2005
- 2005-01-20 CO CO05004558A patent/CO5670350A2/es not_active Application Discontinuation
-
2006
- 2006-10-03 US US11/538,155 patent/US20070105921A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE60315664D1 (de) | 2007-09-27 |
| CN1324017C (zh) | 2007-07-04 |
| EP1532123A1 (en) | 2005-05-25 |
| NO20045497D0 (no) | 2004-12-16 |
| PL374999A1 (en) | 2005-11-14 |
| EA008389B1 (ru) | 2007-04-27 |
| CN1662510A (zh) | 2005-08-31 |
| MXPA04012630A (es) | 2005-09-30 |
| BR0312439A (pt) | 2005-05-10 |
| EP1532123B1 (en) | 2007-08-15 |
| AU2003249344A1 (en) | 2004-01-06 |
| US20070105921A1 (en) | 2007-05-10 |
| NZ537390A (en) | 2006-07-28 |
| JP2005533811A (ja) | 2005-11-10 |
| CO5670350A2 (es) | 2006-08-31 |
| CA2489988A1 (en) | 2003-12-31 |
| HK1081543A1 (zh) | 2006-05-19 |
| IL165763A0 (en) | 2006-01-15 |
| ATE370131T1 (de) | 2007-09-15 |
| US7115747B2 (en) | 2006-10-03 |
| EA200401510A1 (ru) | 2005-06-30 |
| WO2004000821A1 (en) | 2003-12-31 |
| US20040063965A1 (en) | 2004-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20045497L (no) | Fremgangsmate for fremstilling av 5-(1,3-oksazol-2-yl)benzosyrederivater | |
| CY1107008T1 (el) | Παραγωγο βενζιμιδαζολης και χρηση ως ανταγωνιστου υποδοχεα aii | |
| EA200500006A1 (ru) | Лекарственное средство для лечения нейродегенеративных заболеваний | |
| WO2004094384A3 (en) | (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease | |
| EA200101194A1 (ru) | Производные 4,5,6,7-тетрагидроиндазола в качестве противоопухолевых средств | |
| ATE354562T1 (de) | Cyclohexylsulfon-derivate als gamma-secretase- inhibitoren | |
| TW200510405A (en) | Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors | |
| EA200501820A1 (ru) | Терапевтические средства для лечения боли | |
| CY1116885T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξυλομεθυλιου | |
| EA200401114A2 (ru) | Замещённые гидроксиэтиламины | |
| DE50304030D1 (de) | Verfahren zur Herstellung von 5-Nitrobenzofuranen | |
| GEP20074045B (en) | (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease | |
| DE602004011255D1 (de) | Phosphinsäurederivate, inhibitoren von beta-sekretase zur behandlung von alzheimer-krankheit | |
| DE602004019778D1 (de) | Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen | |
| NO20070972L (no) | Benzyloksyderivater som MAOB-inhibitorer | |
| RU2004126861A (ru) | Производные пиридинамидов в качестве ингибиторов моноаминоксидазы (мао-в) | |
| JP2007507467A5 (enExample) | ||
| NO20073213L (no) | Fremgangsmate for fremstilling av tiofenglykosidderivater | |
| GB0003257D0 (en) | Heterocyclic compounds and their therapeutic use | |
| NO20033049D0 (no) | Fremgangsmåte for fremstilling av (+/-) trans-4-p-fluorfenyl- 3-hydroksymetyl-1 | |
| NO20054418L (no) | Substituert benzoylureidopyridylpiperidin- og -pyrrolidinkarboksylsyrederivater, deres fremstilling og anvendelse | |
| WO2004067505A3 (en) | Bismuth dithiocarbamate compounds and uses thereof | |
| TW200637856A (en) | Process for producing thiazolidinedion compound and intermediate thereof | |
| WO2004032854A3 (en) | Pharmaceutical compositions for treatment of parkinson's disease | |
| PE20010216A1 (es) | Procedimiento para preparar derivados de 10,11-metanobenzosuberano |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |